Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call

Aastrom Biosciences (NASDAQ: ASTM) announces the
following Webcast:
   What: Aastrom Biosciences First Quarter Fiscal Year End 2006
Investor Conference Call

   When: Wednesday, November 9, 2005 @ 11:00 AM Eastern

   Where: http://www.investorcalendar.com/IC/CEPage.asp?ID=96864

   How: -- For live over the Internet access, simply log on to the
            web at the address above.

        -- For phone access, interested parties should call
            toll-free [phone] before the start of the
            call to register and identify themselves as
            registrants of the "Aastrom Conference Call". Any
            registered caller on the toll-free line may ask
            for call operator for directions to be placed in
            the queue for the Question & Answer session.

        -- To download the podcast, simply log on to the web
            at the address above.

   If you are unable to participate during the live webcast, the call
will be available for replay at http://www.investorcalendar.com/ for
60 days.
   Aastrom Biosciences, Inc. (Nasdaq: ASTM) is developing
patient-specific products for the repair or regeneration of human
tissues, utilizing the Company's proprietary adult stem cell
technology. Aastrom's strategic position in the tissue regeneration
sector is enabled by its proprietary Tissue Repair Cells (TRCs), a mix
of bone marrow-derived adult stem and progenitor cells manufactured in
the AastromReplicell(R) System, an industry-unique automated cell
production system. TRCs are the core component of the products Aastrom
is developing for severe bone fractures, ischemic vascular disease,
jaw reconstruction and spine fusion, with Phase I/II level clinical
trials active in the U.S. and EU for some of these indications.

   For more information, visit Aastrom's website at www.aastrom.com.